Three Inferior Oblique Weakening Procedures for Management of Mild Hypertropia in Unilateral Superior Oblique Muscle Palsy

三种下斜肌减弱术治疗单侧上斜肌麻痹引起的轻度上斜视

阅读:1

Abstract

PURPOSE: To investigate the surgical outcomes of three different types of inferior oblique muscle weakening procedures in patients with mild hypertropia due to unilateral superior oblique muscle palsy. METHODS: We reviewed surgical data of patients aged  >  30 years with unilateral superior oblique palsy. The patients were categorized into three groups in terms of the surgical procedure: inferior oblique myectomy (IOM), inferior oblique recession (IOR), and inferior oblique disinsertion (IOD). Patients with preoperative hypertropia of 6 to 10 prism diopters (PD) were selected as mild cases for further comparison. Demographic data, preoperative and postoperative deviations in the primary position, contralateral gaze, contralateral elevation gaze, and ipsilateral tilt were considered for analysis. Complete success was defined as achieving postoperative orthotropia in addition to the resolution of diplopia and head tilt. RESULTS: A total of 82 patients with an average age of 11.8 years were included in this study. The male-to-female ratio was 1.27, and the most common cause of palsy was congenital (89%). Fifty-six patients were treated with IOM, thirteen with IOR, and thirteen with IOD. The mean hypertropia correction was significantly better in the IOM group (9.1 PD) than in the IOR (7.1 PD) and IOD (7.5 PD) groups. Complete success was achieved in 80.3% of the IOM group, 69.2% of the IOR group, and 84.6% of the IOD group. The reoperation rate was 1.7% in the IOM group and 7.6% in the IOR group. CONCLUSION: Compared to IOR and IOD procedures, IOM was more effective in correcting hypertropia in patients with inferior oblique muscle overaction and mild hypertropia secondary to unilateral superior oblique palsy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。